A novel anti-inflammation and anti-fibrosis agent, VCP979, treatment attenuates ventricular remodeling and improves cardiac function in murine model of myocardial ischemia/reperfusion injury

Category Primary study
JournalCirculation
Year 2019
This article has no abstract
Epistemonikos ID: 3aa29344577ca71df71a8e85c75d6954cf514c22
First added on: Feb 11, 2025